EASTHAM KARIN 4
4 · VERACYTE, INC. · Filed Jun 11, 2024
Insider Transaction Report
Form 4
VERACYTE, INC.VCYT
EASTHAM KARIN
Director
Transactions
- Exercise/Conversion
Stock Option (right to buy)
2024-06-07−2,500→ 7,500 totalExercise: $10.41Exp: 2025-05-18→ Common Stock (2,500 underlying) - Exercise/Conversion
Common Stock
2024-06-07$10.41/sh+2,500$26,025→ 35,625 total - Sale
Common Stock
2024-06-07$20.97/sh−2,500$52,425→ 33,125 total
Footnotes (2)
- [F1]The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on March 8, 2024.
- [F2]The option is fully vested.